Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
Richardson Electronics
RELL
$267M
| $14K | ﹤0.01% |
3,432
| – | – |
|
5202
Senseonics Holdings Inc
SENS
$263M
| $14K | ﹤0.01% |
1,753
-8,658
| -83% | -$89.5K |
|
|
SOHU
5203
PUT
Sohu.com
SOHU
$362M
| $14K | ﹤0.01% |
1,500
-6,400
| -81% | -$49.9K |
|
|
GWGH
5204
DELISTED
GWG Holdings, Inc
GWGH
| $14K | ﹤0.01% |
1,712
+753
| +79% | +$6.28K |
|
|
AXAS
5205
DELISTED
Abraxas Petroleum Corp
AXAS
| $14K | ﹤0.01% |
2,949
+311
| +12% | +$1.41K |
|
|
NBL
5206
PUT
DELISTED
Noble Energy, Inc.
NBL
| $14K | ﹤0.01% |
1,600
-20,500
| -93% | -$183K |
|
5207
Aclaris Therapeutics
ACRS
$726M
| $13K | ﹤0.01% |
8,294
-2,222
| -21% | -$2.98K |
|
5208
CALL
Electronic Arts
EA
$53B
| $13K | ﹤0.01% |
100
-79,200
| -100% | -$9.36M |
|
5209
EyePoint Inc
EYPT
$1.03B
| $13K | ﹤0.01% |
1,787
-299
| -14% | -$2.57K |
|
5210
KLX Energy Services
KLXE
$45M
| $13K | ﹤0.01% |
1,165
-2,342
| -67% | -$18.6K |
|
5211
Methanex
MEOH
$4.3B
| $13K | ﹤0.01% |
685
-283
| -29% | -$4.7K |
|
5212
Oramed Pharmaceuticals
ORMP
$167M
| $13K | ﹤0.01% |
3,823
| – | – |
|
5213
Pangaea Logistics
PANL
$498M
| $13K | ﹤0.01% |
+5,319
| New | +$11.6K |
|
|
PBPB
5214
DELISTED
Potbelly
PBPB
| $13K | ﹤0.01% |
5,720
-1,211
| -17% | -$3.32K |
|
|
SA
5215
Seabridge Gold
SA
$2.78B
| $13K | ﹤0.01% |
743
-12,102
| -94% | -$171K |
|
5216
SandRidge Energy
SD
$514M
| $13K | ﹤0.01% |
9,692
-602
| -6% | -$903 |
|
5217
PUT
Titan Machinery
TITN
$396M
| $13K | ﹤0.01% |
1,200
-1,000
| -45% | -$9.56K |
|
|
HPR
5218
DELISTED
HighPoint Resources Corporation
HPR
| $13K | ﹤0.01% |
859
-966
| -53% | -$14K |
|
|
ROSE
5219
DELISTED
Rosehill Resources Inc. Class A
ROSE
| $13K | ﹤0.01% |
17,595
+14,103
| +404% | +$6.8K |
|
5220
Biglari Holdings Class A
BH.A
$1.25B
| $12K | ﹤0.01% |
+36
| New | +$12.1K |
|
|
BLDP
5221
Ballard Power Systems
BLDP
$805M
| $12K | ﹤0.01% |
+806
| New | +$8.82K |
|
5222
Celcuity
CELC
$4.21B
| $12K | ﹤0.01% |
1,685
-252
| -13% | -$1.77K |
|
5223
Comp X International
CIX
$349M
| $12K | ﹤0.01% |
838
+296
| +55% | +$4.22K |
|
5224
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $12K | ﹤0.01% |
72
| – | – |
|
5225
vTv Therapeutics
VTVT
$127M
| $12K | ﹤0.01% |
131
+90
| +220% | +$8.89K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.